DysmenorrheaNCT06896851
The Effect of Su Jok on Dysmenorrhea
A study testing Su Jok in people with Dysmenorrhea, run by Ankara Medipol University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to determine the effect of Su Jok application in reducing menstrual pain.The main question it aims to answer is -Is Su Jok practice effective in reducing the severity of dysmenorrhea? The researcher will perform a sham application to see the effect of the application. Read more about this study
- Who is it for?
- Ages 18 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Dysmenorrhea
- What is being tested?
- Su Jok
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 34 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Mar 2024to 30 Jun 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- regular menstrual cycles (21-35 days)
- have abdominal pain in the last three cycles
- Those who want to participate in the study as a volunteer
Who cannot join
- have any health problems that may affect the menstrual cycle (ovarian cysts, etc.
- use hormonal medications
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Fenerbahçe University
Istanbul, Ataşehir, 34758
About this study
Official title: The Effect of Su Jok on Dysmenorrhea:Randomized Placebo-Controlled Trial
This study aims to determine the effect of Su Jok application in reducing menstrual pain.The main question it aims to answer is
-Is Su Jok practice effective in reducing the severity of dysmenorrhea? The researcher will perform a sham application to see the effect of the application.
Participants will perform the application on the first day they have pain during their 3 menstrual cycles. They will evaluate and record their pain with VAS.
- Conditions
- Dysmenorrhea
- Being tested
- Su Jok, Sham point using
- Keywords
- dysmenorrhea, pain, su jok
- Medical subject headings
- Dysmenorrhea, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Su JokOther
a type of acupressure includs hand massage
Sham point usingOther
unrelated point using for acupressing
| Study group | Role | What they receive |
|---|---|---|
| Su Jok Group | Experimental | Sujok is applied with black pepper seeds to the appropriate point on the hand. Receives: Other: Su Jok |
| Placebo Control Group | Sham comparator | Black pepper seeds are applied to the sham point. Receives: Other: Sham point using |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain assesment
Pain assessment is made with Visual Analog Scale(0-10 points, high score means pain severity is high) in three menstrual cycles (up to 105 days).
Measured: " Every hour until 4 hours after the onset of pain on the first day of the cycle (each cycle is 28-35 days) and it will be for 3 cycle.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Mar 2025
- Study start1 Mar 2024
- Primary completion30 Jun 2024
- Study completion30 Jun 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DysmenorrheaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ankara Medipol University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hülya Elmalı Şimşek, Ankara Medipol University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06896851
- Sponsor's protocol ID
- 14.2024fbu
- Status last verified
- Mar 2025
- First submitted
- 4 Mar 2025
- Last updated
- 26 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Data can be shared when the research is accepted for publication.
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Su Jok on Dysmenorrhea:Randomized Placebo-Controlled Trial
- ClinicalTrials.gov ID
- NCT06896851
- Acronym / sponsor ID
- 14.2024fbu
- Conditions
- Dysmenorrhea
- Keywords
- dysmenorrhea, pain, su jok
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- Ankara Medipol UniversityUniversity, hospital or other
- Study start
- 1 Mar 2024 (actual)
- Primary completion
- 30 Jun 2024 (actual)
- Study completion
- 30 Jun 2024 (actual)
- First posted
- 26 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to determine the effect of Su Jok application in reducing menstrual pain.The main question it aims to answer is
-Is Su Jok practice effective in reducing the severity of dysmenorrhea? The researcher will perform a sham application to see the effect of the application.
Participants will perform the application on the first day they have pain during their 3 menstrual cycles. They will evaluate and record their pain with VAS.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Su Jok Group | Experimental | Other: Su JokSujok is applied with black pepper seeds to the appropriate point on the hand. |
| Placebo Control Group | Sham comparator | Other: Sham point usingBlack pepper seeds are applied to the sham point. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- regular menstrual cycles (21-35 days)
- have abdominal pain in the last three cycles
- Those who want to participate in the study as a volunteer
Key exclusion criteria (2 listed)
- have any health problems that may affect the menstrual cycle (ovarian cysts, etc.
- use hormonal medications
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Su Joka type of acupressure includs hand massage | Other | Su Jok Group |
| Sham point usingunrelated point using for acupressing | Other | Placebo Control Group |
Primary outcome
Pain assesment
Time frame: " Every hour until 4 hours after the onset of pain on the first day of the cycle (each cycle is 28-35 days) and it will be for 3 cycle.
Pain assessment is made with Visual Analog Scale(0-10 points, high score means pain severity is high) in three menstrual cycles (up to 105 days).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2025.
- Individual participant dataSharing planned: Undecided. Data can be shared when the research is accepted for publication.
Related trials for Dysmenorrhea
Not yet recruiting
Radiofrequency and Pelvic Floor Exercise for Primary Dysmenorrhea
Primary Dysmenorrhea
Not yet recruitingPhase 2
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Endometriosis Pelvic, Endometriosis Ovaries
Not yet recruiting
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Adenomyosis, Adenomyoma of Uterus
Active, not recruiting
Mindfulness-Based Education For Women With Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS), Menstrual Symptoms
Not yet recruiting
The Effect of a Ginger Formula on Menstrual Health vs a Placebo
Painful Menstruation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Su Jok in people with Dysmenorrhea, run by Ankara Medipol University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain assesment (time frame: " Every hour until 4 hours after the onset of pain on the first day of the cycle (each cycle is 28-35 days) and it will be for 3 cycle.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.